📖 Read more: Nasal Vaccine Targets COVID, Flu, and Pneumonia at Once
🧬 The Problem with Current Flu Vaccines
The influenza virus is one of the most “cunning” enemies of public health. Its ability to mutate rapidly means that a new vaccine is needed every year. Scientists must “guess” which strains will dominate months before the flu season begins.
This happens due to two mutation mechanisms:
Antigenic Drift
Small, gradual mutations in the surface proteins (hemagglutinin and neuraminidase) that occur continuously. This is why we need annual vaccination.
Antigenic Shift
Dramatic reassortment of genetic material between different flu strains. This mechanism caused the pandemics of 1918, 1957, 1968, and 2009.
💡 The Revolutionary Approach: Targeting Stable Structures
The new nasal spray follows a radically different philosophy. Instead of targeting the mutating surface proteins, it focuses on the hemagglutinin stalk — the stable part of the protein that remains virtually unchanged across all flu strains.
Hemagglutinin resembles a "mushroom": the cap (head) constantly changes, but the stalk remains nearly identical. By targeting the stalk, the nasal spray can theoretically neutralize any strain of flu — even future ones.
Conventional Vaccine vs New Nasal Spray
📖 Read more: AI Monitors Every Neuron in Worms and Jellyfish Live
🔬 How the Spray Works
The nasal spray uses specially designed monoclonal antibodies that bind to the conserved region of the hemagglutinin stalk. These antibodies prevent the virus from fusing with the cell membrane, blocking infection at its source.
The nasal spray delivery is deliberate: the flu virus enters the body through the respiratory mucosa. Local administration of IgA antibodies directly to the nasal mucosa means protection is provided exactly where it's needed.
Preclinical Trial Results
In preclinical trials, the nasal spray provided protection against multiple Type A influenza subtypes, including H1N1, H3N2, and H5N1 (avian flu). Animals that received the spray showed significantly reduced viral load in the respiratory system, with minimal side effects.
📖 Read more: One Gene Switches Caring Fathers Into Aggressors
🌍 Why This Is So Important
Pandemic Preparedness
The flu remains the number one pandemic threat. A formulation that works against all strains would be an invaluable tool against future pandemics.
Easy Administration
The nasal spray is painless, doesn't require refrigeration, doesn't need trained personnel for administration, and is ideal for children who fear injections.
Immediate Protection
Unlike vaccines that need 2-3 weeks for immunity to develop, the nasal spray provides protection almost immediately, as the antibodies are already ready.
Avian Flu (H5N1)
With the threat of avian flu remaining relevant, a pandemic H5N1 strain transmissible between humans would meet its match in this spray.
«For decades, we tried to predict which flu strain would appear each winter. With this approach, we no longer need to guess. We target what doesn't change.»
⏳ When Will It Be Available?
The formulation is still in the early stages of clinical trials. The path from the laboratory to the pharmacy is long and requires:
- Phase I: Safety trials in a small number of volunteers (6-12 months)
- Phase II: Efficacy trials in hundreds of participants (1-2 years)
- Phase III: Large clinical trials in thousands of people (2-3 years)
- Approval: Evaluation by FDA/EMA (6-12 months)
It is estimated that 5-8 years will be needed for broad-use approval — if all goes well. However, in the event of a pandemic, the process could be significantly accelerated.